Project Snow White: Internal probe reveals former MiMedx C-suite spied on employees, lied to regulators and misled investors
A 15-month long sweeping internal investigation, encompassing more than a million documents, thousands of hours of secret video surveillance and over 80 witnesses, has brought to light the scandalous past of wound care company MiMedx.
The company, which has long been criticized for its business practices, sells injectable treatments — derived from the amniotic tissue — to treat burns and soft tissue wounds, and counts veterans and military hospitals as its customers. MiMedx has also faced the ire of FDA, which has previously accused it of flagrant manufacturing violations and indicated MiMedx’s suite of products does not meet its regulatory standards.
Basic subscription required
Unlock this story instantly and join 53,400+ biopharma pros reading Endpoints daily — and it's free.